UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Azenta Inc (AZTA)

Azenta Inc (AZTA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
25.50 -0.41 (-1.58%) 04/16/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 25.42 -0.08 (-0.31%) 19:49 ET
Quote Overview for Wed, Apr 16th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
25.01
Day High
26.61
Open 26.61
Previous Close 25.91 25.91
Volume 846,100 846,100
Avg Vol 863,570 863,570
Stochastic %K 9.28% 9.28%
Weighted Alpha -59.77 -59.77
5-Day Change -4.11 (-13.88%) -4.11 (-13.88%)
52-Week Range 25.01 - 63.58 25.01 - 63.58
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,183,983
  • Shares Outstanding, K 45,696
  • Annual Sales, $ 656,320 K
  • Annual Income, $ -164,170 K
  • EBIT $ -69 M
  • EBITDA $ 131 M
  • 60-Month Beta 1.66
  • Price/Sales 1.92
  • Price/Cash Flow 6.07
  • Price/Book 0.73

Options Overview Details

View History
  • Implied Volatility 79.70% ( -7.23%)
  • Historical Volatility 76.70%
  • IV Percentile 96%
  • IV Rank 85.54%
  • IV High 87.94% on 04/14/25
  • IV Low 30.94% on 08/30/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 79
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 2,650
  • Open Int (30-Day) 3,776

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.09
  • Number of Estimates 2
  • High Estimate 0.09
  • Low Estimate 0.09
  • Prior Year 0.05
  • Growth Rate Est. (year over year) +80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.01 +1.96%
on 04/16/25
Period Open: 36.80
38.57 -33.89%
on 03/24/25
-11.30 (-30.71%)
since 03/14/25
3-Month
25.01 +1.96%
on 04/16/25
Period Open: 53.00
55.63 -54.17%
on 02/06/25
-27.50 (-51.89%)
since 01/16/25
52-Week
25.01 +1.96%
on 04/16/25
Period Open: 52.18
63.58 -59.89%
on 07/31/24
-26.68 (-51.13%)
since 04/16/24

Most Recent Stories

More News
3 of Wall Street’s Favorite Stocks in the Doghouse

3 of Wall Street’s Favorite Stocks in the Doghouse

MTW : 7.48 (-0.40%)
TDS : 36.16 (-2.09%)
AZTA : 25.50 (-1.58%)
3 Reasons AZTA is Risky and 1 Stock to Buy Instead

3 Reasons AZTA is Risky and 1 Stock to Buy Instead

NOW : 796.66 (-2.43%)
AZTA : 25.50 (-1.58%)
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

FTRE : 5.02 (+3.29%)
UFPT : 205.45 (+0.48%)
AZTA : 25.50 (-1.58%)
RGEN : 132.10 (+4.33%)
IQV : 148.44 (-0.48%)
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 5.02 (+3.29%)
UFPT : 205.45 (+0.48%)
AZTA : 25.50 (-1.58%)
WST : 209.13 (-1.59%)
IQV : 148.44 (-0.48%)
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

MEDP : 296.50 (-2.79%)
FTRE : 5.02 (+3.29%)
AZTA : 25.50 (-1.58%)
RGEN : 132.10 (+4.33%)
CRL : 104.25 (-1.58%)
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 5.02 (+3.29%)
MEDP : 296.50 (-2.79%)
AZTA : 25.50 (-1.58%)
WST : 209.13 (-1.59%)
IQV : 148.44 (-0.48%)
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 5.02 (+3.29%)
UFPT : 205.45 (+0.48%)
AZTA : 25.50 (-1.58%)
WST : 209.13 (-1.59%)
CRL : 104.25 (-1.58%)
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

FTRE : 5.02 (+3.29%)
UFPT : 205.45 (+0.48%)
AZTA : 25.50 (-1.58%)
RGEN : 132.10 (+4.33%)
WST : 209.13 (-1.59%)
1 Small-Cap Stock with Exciting Potential and 2 to Brush Off

1 Small-Cap Stock with Exciting Potential and 2 to Brush Off

DY : 152.32 (+0.16%)
SLGN : 49.00 (-0.02%)
AZTA : 25.50 (-1.58%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

FTRE : 5.02 (+3.29%)
MEDP : 296.50 (-2.79%)
RGEN : 132.10 (+4.33%)
AZTA : 25.50 (-1.58%)
IQV : 148.44 (-0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta...

See More

Key Turning Points

3rd Resistance Point 28.00
2nd Resistance Point 27.31
1st Resistance Point 26.40
Last Price 25.50
1st Support Level 24.80
2nd Support Level 24.11
3rd Support Level 23.20

See More

52-Week High 63.58
Fibonacci 61.8% 48.85
Fibonacci 50% 44.30
Fibonacci 38.2% 39.74
Last Price 25.50
52-Week Low 25.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro